Klox Technologies has agreed to sell its professional in-office whitening kit business and teeth-whitening pen business to Valeant Pharmaceuticals International.
Financial terms include an upfront payment and a double-digit royalty stream based on product sales during the next 10 years.
Valeant is planning to launch the products in the U.S. in early 2013 through its dental affiliate, OraPharma.
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
